Get access

Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004

Authors

  • Geoffrey C. Nguyen MD, PhD,

    Corresponding author
    1. Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
    2. Mount Sinai Hospital IBD Centre, University of Toronto School of Medicine, Toronto, Ontario, Canada
    • 600 University Ave., Rm. 441, Toronto, ON M5G 1X5
    Search for more papers by this author
  • Anne Tuskey MD,

    1. Mount Sinai Hospital IBD Centre, University of Toronto School of Medicine, Toronto, Ontario, Canada
    Search for more papers by this author
  • Themistocles Dassopoulos MD,

    1. Mount Sinai Hospital IBD Centre, University of Toronto School of Medicine, Toronto, Ontario, Canada
    Search for more papers by this author
  • Mary L. Harris MD,

    1. Mount Sinai Hospital IBD Centre, University of Toronto School of Medicine, Toronto, Ontario, Canada
    Search for more papers by this author
  • Steven R. Brant MD

    1. Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
    2. Mount Sinai Hospital IBD Centre, University of Toronto School of Medicine, Toronto, Ontario, Canada
    Search for more papers by this author

  • These findings were presented as a poster at Digestive Disease Week 2007.

Abstract

Background: Recent epidemiological studies suggest that the prevalences of Crohn's disease (CD) and ulcerative colitis (UC) are increasing in the United States. We sought to determine whether nationwide rates of inflammatory bowel disease (IBD) hospitalizations have increased in response to temporal trends in prevalence.

Methods: We identified all admissions with a primary diagnosis of CD or UC, or 1 of their complications in the Nationwide Inpatient Sample between 1998 and 2004. National estimates of hospitalization rates and rates of surgery were determined using the U.S. Census population as the denominator.

Results: There were an estimated 359,124 and 214,498 admissions for CD and UC, respectively. The overall hospitalization rate for CD was 18.0 per 100,000 and that for UC was 10.8 per 100,000. There was a 4.3% annual relative increase in hospitalization rate for CD (P < 0.0001) and a 3.0% annual increase for UC (P < 0.0001). Surgery rates were 3.4 bowel resections per 100,000 for CD and 1.2 colectomies per 100,000 for UC and remained stable. There were no temporal patterns for average length of stay for CD (5.8 days) or for UC (6.8 days). The national estimate of total inpatient charges attributable to CD increased from $762 million to $1,330 million between 1998 and 2004, and that for UC increased from $592 million to $945 million.

Conclusions: Hospitalization rates for IBD, particularly CD, have increased within a 7-year period, incurring a substantial rise in inflation-adjusted economic burden. The findings reinforce the need for effective treatment strategies to reduce IBD complications.

(Inflamm Bowel Dis 2007)

Ancillary